- Home
- SITM vs KLTOW Comparison
SITM vs KLTOW Comparison
Compare SITM & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SITM
- KLTOW
- Stock Information
- Founded
- SITM 2003
- KLTOW N/A
- Country
- SITM United States
- KLTOW United States
- Employees
- SITM N/A
- KLTOW 3
- Industry
- SITM Semiconductors
- KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SITM Technology
- KLTOW Health Care
- Exchange
- SITM Nasdaq
- KLTOW Nasdaq
- Market Cap
- SITM N/A
- KLTOW N/A
- IPO Year
- SITM 2019
- KLTOW 2022
- Fundamental
- Price
- SITM $190.01
- KLTOW $0.02
- Analyst Decision
- SITM Strong Buy
- KLTOW
- Analyst Count
- SITM 5
- KLTOW 0
- Target Price
- SITM $215.00
- KLTOW N/A
- AVG Volume (30 Days)
- SITM 264.0K
- KLTOW N/A
- Earning Date
- SITM 05-07-2025
- KLTOW N/A
- Dividend Yield
- SITM N/A
- KLTOW N/A
- EPS Growth
- SITM N/A
- KLTOW N/A
- EPS
- SITM N/A
- KLTOW N/A
- Revenue
- SITM $229,989,000.00
- KLTOW N/A
- Revenue This Year
- SITM $29.96
- KLTOW N/A
- Revenue Next Year
- SITM $22.81
- KLTOW N/A
- P/E Ratio
- SITM N/A
- KLTOW N/A
- Revenue Growth
- SITM 65.85
- KLTOW N/A
- 52 Week Low
- SITM $105.40
- KLTOW N/A
- 52 Week High
- SITM $268.18
- KLTOW N/A
- Technical
- Relative Strength Index (RSI)
- SITM 70.01
- KLTOW N/A
- Support Level
- SITM $158.63
- KLTOW N/A
- Resistance Level
- SITM $167.86
- KLTOW N/A
- Average True Range (ATR)
- SITM 9.36
- KLTOW 0.00
- MACD
- SITM 5.94
- KLTOW 0.00
- Stochastic Oscillator
- SITM 91.87
- KLTOW 0.00
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.